Vascular expression of E-selectin is increased in estrogen-receptor- negative breast cancer: A role for tumor-cell-secreted interleukin-1α

Mai Nguyen, Christopher Corless, Birgit M. Kräling, Chanh Tran, Tom Atha, Joyce Bischoff, Sanford H. Barsky

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Angiogenesis plays an important role in breast cancer growth and metastasis. Multiple adhesion molecules have been shown to perform critical functions in the process of angiogenesis. In this study, we analyzed 15 benign and 22 malignant estrogen-receptor-negative and estrogen-receptor- positive breast specimens for the presence of the endothelial cell adhesion molecules E-selectin and P-selectin. We found that E-selectin's expression was increased in the malignant breast tumors compared with their benign counterparts (23.86% of blood vessels versus 2.479%; P = 0.0005). Furthermore, E-selectin staining was found to be significantly increased in the estrogen-receptor-negative carcinomas compared with the estrogen- receptor-positive ones (P = 0.005). In vitro findings strongly correlated with the in vivo findings and showed a higher degree of E-selectin induction in endothelial cells ex posed to conditioned media from estrogen-receptor- negative breast cancer cell lines than from estrogen-receptor-positive ones. The degree of E-selectin induction correlated with the amount of interleukin- 1α in the tumor-conditioned media. Neutralizing antibodies to interleukin- 1α significantly inhibited the E-selectin expression in endothelial cells exposed to tumor-conditioned media. The results indicate that the endothelial E-selectin expression during angiogenesis is related to breast carcinoma progression in vivo and that this component of angiogenesis may be due directly to tumor-cell-secreted interleukin-1α.

Original languageEnglish (US)
Pages (from-to)1307-1314
Number of pages8
JournalAmerican Journal of Pathology
Volume150
Issue number4
StatePublished - 1997
Externally publishedYes

Fingerprint

E-Selectin
Interleukin-1
Estrogen Receptors
Blood Vessels
Breast Neoplasms
Conditioned Culture Medium
Neoplasms
Endothelial Cells
P-Selectin
Cell Adhesion Molecules
Neutralizing Antibodies
Breast
Staining and Labeling
Neoplasm Metastasis
Carcinoma
Cell Line
Growth

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Vascular expression of E-selectin is increased in estrogen-receptor- negative breast cancer : A role for tumor-cell-secreted interleukin-1α. / Nguyen, Mai; Corless, Christopher; Kräling, Birgit M.; Tran, Chanh; Atha, Tom; Bischoff, Joyce; Barsky, Sanford H.

In: American Journal of Pathology, Vol. 150, No. 4, 1997, p. 1307-1314.

Research output: Contribution to journalArticle

Nguyen, Mai ; Corless, Christopher ; Kräling, Birgit M. ; Tran, Chanh ; Atha, Tom ; Bischoff, Joyce ; Barsky, Sanford H. / Vascular expression of E-selectin is increased in estrogen-receptor- negative breast cancer : A role for tumor-cell-secreted interleukin-1α. In: American Journal of Pathology. 1997 ; Vol. 150, No. 4. pp. 1307-1314.
@article{d103c776e1124820b1c4534878d19054,
title = "Vascular expression of E-selectin is increased in estrogen-receptor- negative breast cancer: A role for tumor-cell-secreted interleukin-1α",
abstract = "Angiogenesis plays an important role in breast cancer growth and metastasis. Multiple adhesion molecules have been shown to perform critical functions in the process of angiogenesis. In this study, we analyzed 15 benign and 22 malignant estrogen-receptor-negative and estrogen-receptor- positive breast specimens for the presence of the endothelial cell adhesion molecules E-selectin and P-selectin. We found that E-selectin's expression was increased in the malignant breast tumors compared with their benign counterparts (23.86{\%} of blood vessels versus 2.479{\%}; P = 0.0005). Furthermore, E-selectin staining was found to be significantly increased in the estrogen-receptor-negative carcinomas compared with the estrogen- receptor-positive ones (P = 0.005). In vitro findings strongly correlated with the in vivo findings and showed a higher degree of E-selectin induction in endothelial cells ex posed to conditioned media from estrogen-receptor- negative breast cancer cell lines than from estrogen-receptor-positive ones. The degree of E-selectin induction correlated with the amount of interleukin- 1α in the tumor-conditioned media. Neutralizing antibodies to interleukin- 1α significantly inhibited the E-selectin expression in endothelial cells exposed to tumor-conditioned media. The results indicate that the endothelial E-selectin expression during angiogenesis is related to breast carcinoma progression in vivo and that this component of angiogenesis may be due directly to tumor-cell-secreted interleukin-1α.",
author = "Mai Nguyen and Christopher Corless and Kr{\"a}ling, {Birgit M.} and Chanh Tran and Tom Atha and Joyce Bischoff and Barsky, {Sanford H.}",
year = "1997",
language = "English (US)",
volume = "150",
pages = "1307--1314",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Vascular expression of E-selectin is increased in estrogen-receptor- negative breast cancer

T2 - A role for tumor-cell-secreted interleukin-1α

AU - Nguyen, Mai

AU - Corless, Christopher

AU - Kräling, Birgit M.

AU - Tran, Chanh

AU - Atha, Tom

AU - Bischoff, Joyce

AU - Barsky, Sanford H.

PY - 1997

Y1 - 1997

N2 - Angiogenesis plays an important role in breast cancer growth and metastasis. Multiple adhesion molecules have been shown to perform critical functions in the process of angiogenesis. In this study, we analyzed 15 benign and 22 malignant estrogen-receptor-negative and estrogen-receptor- positive breast specimens for the presence of the endothelial cell adhesion molecules E-selectin and P-selectin. We found that E-selectin's expression was increased in the malignant breast tumors compared with their benign counterparts (23.86% of blood vessels versus 2.479%; P = 0.0005). Furthermore, E-selectin staining was found to be significantly increased in the estrogen-receptor-negative carcinomas compared with the estrogen- receptor-positive ones (P = 0.005). In vitro findings strongly correlated with the in vivo findings and showed a higher degree of E-selectin induction in endothelial cells ex posed to conditioned media from estrogen-receptor- negative breast cancer cell lines than from estrogen-receptor-positive ones. The degree of E-selectin induction correlated with the amount of interleukin- 1α in the tumor-conditioned media. Neutralizing antibodies to interleukin- 1α significantly inhibited the E-selectin expression in endothelial cells exposed to tumor-conditioned media. The results indicate that the endothelial E-selectin expression during angiogenesis is related to breast carcinoma progression in vivo and that this component of angiogenesis may be due directly to tumor-cell-secreted interleukin-1α.

AB - Angiogenesis plays an important role in breast cancer growth and metastasis. Multiple adhesion molecules have been shown to perform critical functions in the process of angiogenesis. In this study, we analyzed 15 benign and 22 malignant estrogen-receptor-negative and estrogen-receptor- positive breast specimens for the presence of the endothelial cell adhesion molecules E-selectin and P-selectin. We found that E-selectin's expression was increased in the malignant breast tumors compared with their benign counterparts (23.86% of blood vessels versus 2.479%; P = 0.0005). Furthermore, E-selectin staining was found to be significantly increased in the estrogen-receptor-negative carcinomas compared with the estrogen- receptor-positive ones (P = 0.005). In vitro findings strongly correlated with the in vivo findings and showed a higher degree of E-selectin induction in endothelial cells ex posed to conditioned media from estrogen-receptor- negative breast cancer cell lines than from estrogen-receptor-positive ones. The degree of E-selectin induction correlated with the amount of interleukin- 1α in the tumor-conditioned media. Neutralizing antibodies to interleukin- 1α significantly inhibited the E-selectin expression in endothelial cells exposed to tumor-conditioned media. The results indicate that the endothelial E-selectin expression during angiogenesis is related to breast carcinoma progression in vivo and that this component of angiogenesis may be due directly to tumor-cell-secreted interleukin-1α.

UR - http://www.scopus.com/inward/record.url?scp=0030945933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030945933&partnerID=8YFLogxK

M3 - Article

C2 - 9094987

AN - SCOPUS:0030945933

VL - 150

SP - 1307

EP - 1314

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 4

ER -